References and Notes
<A NAME="RG23409ST-1A">1a</A>
Bentley KW. In The Isoquinoline Alkaloids
Part
5, Vol. 1:
Ravindranath B.
Hartwood
Academic;
Banglore:
1998.
p.93-106
<A NAME="RG23409ST-1B">1b</A>
Castedo L.
Suau R. In The Alkaloids
Part
6, Vol. 29:
Brossi A.
Academic
Press;
Orlando:
1986.
p.287-324
<A NAME="RG23409ST-2">2</A>
Rodriguez de Lera A.
Suau R.
Castedo L.
J.
Heterocycl. Chem.
1987,
24:
313
<A NAME="RG23409ST-3">3</A>
Suau R.
Lopez-Romero JM.
Rico R.
Alonso FJ.
Lobo C.
Tetrahedron
1996,
52:
11307
<A NAME="RG23409ST-4A">4a</A>
Wijeratne EMK.
Gunatilaka AL.
Kingston DGI.
Haltiwanger RC.
Ehghleston DS.
Tetrahedron
1995,
51:
7877
<A NAME="RG23409ST-4B">4b</A>
Suau R.
Rico R.
Lopez-Romero JM.
Najera F.
Ruiz A.
Ortiz-Lopez FJ.
Arkivoc
2002,
(v):
62
<A NAME="RG23409ST-5A">5a</A>
Richey RN.
Yu H.
Org.
Process Res. Dev.
2009,
13:
315
<A NAME="RG23409ST-5B">5b</A>
Coghlan MJ.
Green JE.
Grese TA.
Jadhav PK.
Matthews DP.
Steinberg MI.
Fales KR.
Bell MG. WO 2004052847 A2, 2004,
<A NAME="RG23409ST-6A">6a</A>
Olivera R.
SanMartin R.
Churruca F.
Dominguez
EJ.
Org. Chem.
2002,
67:
7215 ; and references cited therein
<A NAME="RG23409ST-6B">6b</A>
Dominguez E.
Trends
Heterocycl. Chem.
2003,
9:
259
<A NAME="RG23409ST-6C">6c</A>
Mercep M,
Mesic M, and
Pesic D. inventors; WO 2003099822.
<A NAME="RG23409ST-6D">6d</A>
Peggy PM.
Wilson PD.
Org. Lett.
2003,
5:
4911
<A NAME="RG23409ST-7">7</A> Review:
Missir A.
Limban C.
Stecoza C.
Morusciag L.
Chirita I.
Farmacia
(Bucharest)
1998,
46:
17
<A NAME="RG23409ST-8">8</A>
Kumar S.
Ila H.
Junjappa H.
Tetrahedron
2007,
63:
10067
<A NAME="RG23409ST-9">9</A>
Harrow TA.
Harrison CE.
Williamson WRN.
J. Chem. Soc.C
1971,
2098
<A NAME="RG23409ST-10">10</A>
Neale AJ.
Rawlings TJ.
McCall EB.
Tetrahedron
1965,
21:
1299
<A NAME="RG23409ST-11">11</A>
Balu MP.
Singh G.
Ila H.
Junjappa H.
Tetrahedron Lett.
1986,
27:
117
<A NAME="RG23409ST-12A">12a</A>
Gupta AK.
Ila H.
Junjappa H.
Tetrahedron Lett.
1987,
28:
1459
<A NAME="RG23409ST-12B">12b</A>
Singh G.
Ila H.
Junjappa H.
Tetrahedron
Lett.
1984,
25:
5095
<A NAME="RG23409ST-13">13</A>
Brightwell NE.
Griffin GW.
J. Chem. Soc., Chem. Commun.
1973,
37
<A NAME="RG23409ST-14">14</A>
Campeau L.-C.
Parisien M.
Leblanc M.
Fagnou K.
J. Am. Chem. Soc.
2004,
126:
9186
<A NAME="RG23409ST-15">15</A>
Lafrance M.
Gorelsky SI.
Fagnou K.
J.
Am. Chem. Soc.
2007,
129:
14570
<A NAME="RG23409ST-16">16</A>
Taylor SR.
Ung AT.
Pyne SG.
Skelton BW.
White AH.
Tetrahedron
2007,
63:
11377
<A NAME="RG23409ST-17A">17a</A>
Tominaga Y.
Ushirogochi A.
Matsuda Y.
J. Heterocycl. Chem.
1987,
24:
1557
<A NAME="RG23409ST-17B">17b</A>
Ram VJ.
Verma M.
Hussaini FA.
Shoeb A.
J.
Chem. Res., Synop.
1991,
98
<A NAME="RG23409ST-17C">17c</A>
Ram VJ.
Verma M.
Hussaini FA.
Shoeb A.
Liebigs
Ann. Chem.
1991,
1229
<A NAME="RG23409ST-18">18</A>
Ram VJ.
Nath M.
Srivastava P.
Sarkhel S.
Maulik
PR.
J. Chem. Soc., Perkin Trans. 1
2000,
3719
<A NAME="RG23409ST-19">19</A>
Tandon VK.
Khanna JM.
Anand N.
Tetrahedron
1990,
46:
2871
<A NAME="RG23409ST-20">20</A>
Data for Compounds
General Procedure for the Synthesis of 4-Methylthio-2-oxo-5,6-dihydro-2
H
-benzo[
b
]pyrano[2,3-
d
]oxepine-3-carbonitriles
(5)
A mixture of 3,4-dihydro-2H-benzo[b]oxepin-5 (2H)-one
(1 mmol) and methyl 2-cyano-3,3-dimethylthioacrylate (1, 1 mmol) in DMF (8 mL) in the presence
of powdered KOH (2 mmol) for 5 h. Excess of DMF was removed under
reduced pressure and the residue poured onto crushed ice with vigorous
stirring. The aqueous suspension was neutralized with 10% HCl
(5 mL) and the precipitate obtained was filtered, washed with H2O,
and purified on silica gel column, using 40% hexane in
CH2Cl2 as eluent.
Compound 5c: yellow solid; yield 65%; mp
178 ˚C; IR (KBr): 2956, 2361, 2216 (CN), 1722 (C=O),
1585, 1489, 1271, 1212, 1037, 840, 761, 668, 502 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 2.87 (t, J = 6 Hz,
2 H), 3.01 (s, 3 H, SCH3), 3.83 (s, 3 H, OCH3),
4.47 (t, 2 H, J = 6.0
Hz, OCH2), 7.03 (s, 1 H, ArH), 7.28 (d, J = 9
Hz, 2 H, ArH). ¹³C NMR (300 MHz, CDCl3): δ = 18,
27, 55, 75, 93, 112 (2 C), 114, 115, 120, 123, 124, 150, 155, 158,
168. MS: m/z = 315 [M+]. ESI-HRMS: m/z calcd for C16H14NO4S:
316.0626 [M+ + 1]; found:
316.0643.
General Procedure for the
Synthesis of 8-Phenyl-10-(
sec
-amino)-6,7-dihydrodibenzo[
b
,
d
]oxepine-11-carbonitriles
(6)
A mixture of 3,4-dihydrobenzo[b]oxepine-5 (2H)-ones 4 (1 mmol) and 6-phenyl-4-(sec-amino)-2H-pyran-2-one-3-carbonitriles 3 (1 mmol) in DMF (6 mL) was stirred for
3
h in the presence of powdered KOH (2 mmol). After completion of
the reaction, content was poured onto crushed ice with vigorous
stirring and neutralized with 10% HCl. The precipitate
obtained was filtered, washed with H2O, and dried. The
crude product was purified through silica gel column using a mixture
of hexane-CH2Cl2 (7:3) as eluent and
repurified by abs. MeOH.
Compound 6a:
white solid; yield 44%; mp 144 ˚C. IR (KBr):
3069, 2934, 2850, 2804, 2370, 2218 (CN), 1573, 1496, 1439 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 1.52-1.69
(m, 6 H), 3.06 (m, 2 H), 3.20 (m, 4 H), 3.79 (s, 3 H), 4.24 (m,
2 H), 6.97-7.03 (m, 2 H), 7.08 (s, 1 H), 7.24 (d, 1 H, J = 3.0 Hz),
7.38-7.48 (m, 5 H). ¹³C NMR
(300 MHz, CDCl3): δ = 24, 26 (2 C),
28, 53 (2 C), 55, 78, 105, 115, 116, 118, 119, 122, 127 (2 C), 128
(3 C), 132 (2 C), 140, 143, 146, 148, 155, 156. MS: m/z = 411 [M+ + 1],
412 [M+ + 2]. ESI-HRMS: m/z calcd for C27H27N2O2:
411.20725 [M+ + 1]; found:
411.20728.
General Procedure for the
Synthesis of 2-{4-Phenyl-5,6-dihydro-2
H
-benzo[
b
]pyrano[2,3-d]oxepin-2-ylidene}-acetonitriles
(7)
A mixture of 3,4-dihydrobenzo[b]oxepine-5 (2H)-ones 4 (1 mmol), 6-(4-phenyl-4-methylthio)-2-oxo-2H-pyran-3-carbonitriles 2 (1
mmol) and powdered KOH (2 mmol) in DMF (8 mL) was stirred for 3
h.The reaction mixture was poured onto crushed ice with vigorous
stirring. The aqueous phase was neutralized with 10% HCl,
and the precipitate obtained was filtered, washed with H2O,
and purified on silica gel column using hexane-CH2Cl2 mixture
(7:3) as eluent.
Compound 7b:
red colored solid; yield 55%; mp 200 ˚C;
IR (KBr): 3077, 2927, 2834, 2368, 2189 (CN), 1639, 1570, 1490, 1404
cm-¹. ¹H NMR (300
MHz, CDCl3): δ (Z-isomer, 70%) = 2.50
(s, 2 H, CH2), 3.89 (s, 3 H, OCH3), 4.26 (s,
2 H, OCH2), 6.18 (s, 1 H, CH), 6.65-7.43 (m,
8 H, ArH); δ (E-isomer, 30%) = 2.41
(s, 2 H, CH2), 3.83 (s, 3 H, OCH3), 4.35 (s,
2 H, OCH2), 6.65 (s, 1 H, CH), 6.65-7.43 (m,
8 H, ArH). ¹³C NMR (300 MHz, CDCl3): δ = 31,
55, 65, 72, 110, 112, 115, 116, 117, 118, 119, 122 (2 C), 129 (2
C), 135 (2 C), 146, 150, 151, 155, 164. MS: m/z = 378 [M+],
380 [M+ + 2]. ESI-HRMS: m/z calcd for C22H17ClNO3:
378.0897 [M+ + 1]; found:
378.0889.